DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2016-03-01T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,b29e6518-d55c-ecfc-418a-74bbedb6d7dd,140,Influenza  seasonal  injectable  preservative free,136.0
2016-03-01T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,b29e6518-d55c-ecfc-418a-74bbedb6d7dd,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2016-03-01T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,b29e6518-d55c-ecfc-418a-74bbedb6d7dd,43,Hep B  adult,136.0
2016-03-01T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,b29e6518-d55c-ecfc-418a-74bbedb6d7dd,114,meningococcal MCV4P,136.0
2019-03-05T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,bc22a87a-c4b7-8bc6-bed4-09a299fe85b8,140,Influenza  seasonal  injectable  preservative free,136.0
2021-05-11T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,8b773ac6-277f-3b7e-ebde-e025ce7fcb18,140,Influenza  seasonal  injectable  preservative free,136.0
2021-08-17T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,824361a4-e3b6-3268-70d8-299cd3ef6acb,208,COVID-19  mRNA  LNP-S  PF  30 mcg/0.3 mL dose,136.0
2021-09-07T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,3fd9b6af-1b0f-fa76-1fae-b7e2b3fda9b0,208,COVID-19  mRNA  LNP-S  PF  30 mcg/0.3 mL dose,136.0
2022-03-08T10:49:22Z,bc68f45e-2084-55b8-da5f-db8ca09f8b13,dd40ae34-6aa9-507b-41de-28234e515576,140,Influenza  seasonal  injectable  preservative free,136.0
